Belgium· BE-AMP-SAM330425-00

Actilyse Cathflo 2 mg

A fibrinolysin product containing alteplase, registered in Belgium by Boehringer Ingelheim.

ATC B01AD05

Checked against FAMHP / AFMPS (Belgium) on September 26, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about alteplaseAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

The record

At a glance

FAMHP / AFMPS (Belgium)

Active substance: Alteplase
Manufacturer: Boehringer Ingelheim
Country: Belgium (BE)
ATC code: B01AD05
ATC class: Fibrinolysin
Reimbursed: Not published by this register
Source register: FAMHP / AFMPS (Belgium)
Last checked: September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Fibrinolysin in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All fibrinolysin products

Authorised across Europe · EMA

The same active substance is authorised in 29 EEA countries. Names it is sold under:

Austria · Actilyse, Actilyse Cathflo
Bulgaria · Актилизе
Cyprus · Actilyse, Actilyse Cathflo
Czechia · Actilyse
Germany · Actilyse, Actilyse Cathflo
Denmark · Actilyse
Estonia · Actilyse
Spain · Actilyse
Finland · Actilyse
France · Actilyse
United Kingdom (Northern Ireland) · Actilyse, Actilyse Cathflo
Greece · Actilyse, Actilyse Cathflo
Croatia · Actilyse
Hungary · Actilyse
Ireland · Actilyse, Actilyse Cathflo
Iceland · Actilyse
Italy · Actilyse
Lithuania · Actilyse
Luxembourg · Actilyse, Actilyse Cathflo
Latvia · Actilyse
Malta · Actilyse
Netherlands · Actilyse, Actilyse Cathflo
Norway · Actilyse
Poland · Actilyse 10, Actilyse 20
Portugal · Actilyse, Actilyse Cathflo
Romania · Actilyse
Sweden · Actilyse
Slovenia · Actilyse, Actilyse Cathflo
Slovakia · Actilyse

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/bb4bd2c6-8345-4657-b0f2-5154cf793051
GET /v1/drugs/bb4bd2c6-8345-4657-b0f2-5154cf793051?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Powder for solution for injection/infusion",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Actilyse Cathflo 2 mg",
  "name_fr": "Actilyse Cathflo 2 mg",
  "name_nl": "Actilyse Cathflo 2 mg",
  "amp_code": "SAM330425-00",
  "strengths": [
    "2.0000",
    "0.2000"
  ],
  "pack_count": 2,
  "substances": [
    "Alteplase",
    "Polysorbate 80"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Fibrinolysin",
  "authorisation_numbers": [
    "BE330425"
  ]
}

API reference MCP server Plans

See everything about fibrinolysin.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console